Attendees will be helped to see how to develop a compliant Hazard Analysis/Risk Management File and Report. The US FDA is increasingly stating that many regulated activities should be 'risk-based'. Major resource-consuming activities such as product and process/equipment/facility, and software validation, CAPA investigations, vendor audits can all be tailored to a risk based approach.
This eliminates the current SOP-defined 'one size fits all' approach, to a flexible, resource adjusted approach, less arbitrarily defined in an SOP, but yielding results targeted to real needs. Attendees will be helped to see how to develop a compliant Hazard Analysis/Risk Management File and Report, as outlined in the newly revised ISO 14971:2007, a standard recognized by the FDA and rapidly being adopted by industry. Then how to use this document to accomplish the above goals.
This eliminates the current SOP-defined 'one size fits all' approach, to a flexible, resource adjusted approach, less arbitrarily defined in an SOP, but yielding results targeted to real needs. Attendees will be helped to see how to develop a compliant Hazard Analysis/Risk Management File and Report, as outlined in the newly revised ISO 14971:2007, a standard recognized by the FDA and rapidly being adopted by industry. Then how to use this document to accomplish the above goals.
Areas Covered in the seminar:
- Elements of ISO 14971: Narrative, hazard analysis and the Appendices, risk analysis tools and rankings, the Risk Management File and Report.
- Changes from the previous version.
- Locating and using sources of hazards/risks.
- Parallel approaches to developing the document.
- When to involve teams?
- Who to consider for sign-offs/approvals?
- How to use the completed document;Ways to ensure it remains a 'living (and useful) document'?
- Attendees for this 90-minute webinar will also receive a suggested Risk Management File template.
Who Will Benefit:
- Senior Management.
- Project Leaders.
- Regulatory Affairs.
- R&D and Engineering Staff.
- All charged with new product development, regulatory submissions, initiating/overseeing product hazard analysis and remediation
- CAPA and P&PC personnel desiring to reduce or redirect investigation and validation costs without sacrificing product safety and/or warranty costs.
Course Provider
John E Lincoln,